Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

A modified heterotopic swine hind limb transplant model for translational vascularized composite allotransplantation (VCA) research.

Ibrahim Z, Cooney DS, Shores JT, Sacks JM, Wimmers EG, Bonawitz SC, Gordon C, Ruben D, Schneeberger S, Lee WP, Brandacher G.

J Vis Exp. 2013 Oct 14;(80). doi: 10.3791/50475.

2.

Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.

Jindal R, Unadkat J, Zhang W, Zhang D, Ng TW, Wang Y, Jiang J, Lakkis F, Rubin P, Lee WP, Gorantla VS, Zheng XX.

Am J Transplant. 2015 May;15(5):1231-40. doi: 10.1111/ajt.13118. Epub 2015 Feb 12.

3.

A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.

Ramirez AE, Cheng HY, Lao WW, Wang YL, Wen CJ, Wallace CG, Lin CF, Shih LY, Chuang SH, Wei FC.

Transpl Int. 2014 Sep;27(9):977-86. doi: 10.1111/tri.12364. Epub 2014 Jul 29.

4.

Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy.

Lin CH, Zhang W, Ng TW, Zhang D, Jiang J, Pulikkottil B, Lakkis F, Gorantla VS, Lee WP, Brandacher G, Zheng XX.

Am J Transplant. 2013 Aug;13(8):2161-8. doi: 10.1111/ajt.12275. Epub 2013 May 29.

5.

Split tolerance to a composite tissue allograft in a swine model.

Mathes DW, Randolph MA, Solari MG, Nazzal JA, Nielsen GP, Arn JS, Sachs DH, Lee WP.

Transplantation. 2003 Jan 15;75(1):25-31.

PMID:
12544866
6.

Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.

Kueckelhaus M, Fischer S, Seyda M, Bueno EM, Aycart MA, Alhefzi M, ElKhal A, Pomahac B, Tullius SG.

Transpl Int. 2016 Jun;29(6):655-62. doi: 10.1111/tri.12652. Epub 2015 Sep 14. Review.

7.

Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.

Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS.

Transplantation. 2015 Sep;99(9):1765-73. doi: 10.1097/TP.0000000000000731.

8.

The need for inducing tolerance in vascularized composite allotransplantation.

Ravindra KV, Xu H, Bozulic LD, Song DD, Ildstad ST.

Clin Dev Immunol. 2012;2012:438078. doi: 10.1155/2012/438078. Epub 2012 Oct 31. Review.

9.

Monitoring and long-term outcomes in vascularized composite allotransplantation.

Kaufman CL, Ouseph R, Marvin MR, Manon-Matos Y, Blair B, Kutz JE.

Curr Opin Organ Transplant. 2013 Dec;18(6):652-8. doi: 10.1097/MOT.0000000000000025. Review.

PMID:
24220047
10.

Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Leonard DA, Kurtz JM, Mallard C, Albritton A, Duran-Struuck R, Farkash EA, Crepeau R, Matar A, Horner BM, Randolph MA, Sachs DH, Huang CA, Cetrulo CL Jr.

Am J Transplant. 2014 Feb;14(2):343-55. doi: 10.1111/ajt.12560. Epub 2014 Jan 9.

11.
12.

The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.

Plock JA, Schnider JT, Schweizer R, Zhang W, Tsuji W, Waldner M, Solari MG, Marra KG, Rubin JP, Gorantla VS.

Transplantation. 2017 Jan;101(1):e1-e11. doi: 10.1097/TP.0000000000001498.

PMID:
27893612
13.

A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts.

Adamson LA, Huang WC, Breidenbach WC, Rahhal D, Xu H, Huang Y, Pidwell DJ, Wei FC, Tobin G, Ildstad ST.

Microsurgery. 2007;27(7):630-6.

PMID:
17868137
14.

Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.

Olariu R, Denoyelle J, Leclère FM, Dzhonova DV, Gajanayake T, Banz Y, Hayoz M, Constantinescu M, Rieben R, Vögelin E, Taddeo A.

J Surg Res. 2017 Oct;218:49-57. doi: 10.1016/j.jss.2017.05.046. Epub 2017 Jun 10.

PMID:
28985877
15.

Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.

Barth RN, Rodriguez ED, Mundinger GS, Nam AJ, Ha JS, Hui-Chou H, Jones LS, Panda A, Shipley ST, Drachenberg CB, Kukuruga D, Bartlett ST.

Am J Transplant. 2011 Jul;11(7):1407-16. doi: 10.1111/j.1600-6143.2011.03551.x. Epub 2011 Jun 10.

16.

Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.

Wachtman GS, Wimmers EG, Gorantla VS, Lin CH, Schneeberger S, Unadkat JV, Zheng XX, Brandacher G, Lee WP.

Transplant Proc. 2011 Nov;43(9):3541-4. doi: 10.1016/j.transproceed.2011.10.010.

PMID:
22099837
17.

Current concepts and systematic review of vascularized composite allotransplantation of the abdominal wall.

Berli JU, Broyles JM, Lough D, Shridharani SM, Rochlin D, Cooney DS, Lee WP, Brandacher G, Sacks JM.

Clin Transplant. 2013 Nov-Dec;27(6):781-9. doi: 10.1111/ctr.12243. Epub 2013 Sep 16. Review.

PMID:
24102820
18.

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model.

Kotsougiani D, Hundepool CA, Willems JI, Friedrich P, Shin AY, Bishop AT.

J Vis Exp. 2017 Aug 13;(126). doi: 10.3791/55238.

PMID:
28829409
19.

Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.

Friedman O, Carmel N, Sela M, Abu Jabal A, Inbal A, Ben Hamou M, Krelin Y, Gur E, Shani N.

PLoS One. 2017 Jul 26;12(7):e0181507. doi: 10.1371/journal.pone.0181507. eCollection 2017.

20.

Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?

Cetrulo CL Jr, Torabi R, Scalea JR, Shimizu A, Leto Barone AA, Gillon BC, Tasaki M, Leonard DA, Cormack TA, Villani V, Randolph MA, Sachs DH, Yamada K.

Transplantation. 2013 Dec 15;96(11):966-74. doi: 10.1097/TP.0b013e3182a579d0.

Supplemental Content

Support Center